← All trials
NCT07280234
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 14, 2024
- Primary completion
- May 15, 2025
- Completion date
- May 15, 2025
- First posted
- Dec 12, 2025
- Last posted
- Dec 12, 2025
- Enrollment
- 218
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hayat Abad Medical Complex, Peshawar.Lead sponsor
- Hayat Abad Medical Complex, Peshawar.Sponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.